Company name:
Advanced Drainage Systems Inc
-
IPO SHARE PRICE:$16.00
-
IPO DATE:July 25, 2014
-
TICKER:WMS
-
MAIN STOCK EXCHANGE:New York Stock Exchange
-
CURRENT HQ LOCATION:4640 Trueman Boulevard Hilliard Ohio 43026
-
FISCAL YEAR END:March 31
-
INCORPORATION JURISDICTION:DE
-
ORGANIZED AS THE FOLLOWING LEGAL TYPE:Corporation
-
Investor Relations Webpage:Coming soon!
-
TAX RATE:USA federal corporate nominal income tax rate is 21%
Short Description
Advanced Drainage Systems Inc
We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com
Statement of Cash Flow
(USD in thousand)
Selected Year:
31-Mar
2020
2020
OPERATING ACTIVITIES
Cash received and spent on operating activites of business — buying materials, paying salaries, receiving payments from clients, etc
48.3% -
ESOP special dividend compensation
24.5% -
Depreciation and amortization
6.8% -
Amortization of deferred financing costs
6.3% -
Stock-based compensation
6.2% -
Accounts payable accrued expenses and other liabilities
3.7% -
Inventory
1.5% -
Inventory step up related to Infiltrator Water Technologies acquisition
1.0% -
(Gain) loss on sale of assets and related costs
1.0% -
Receivables
0.6% -
Change in fair value of derivative
SOURCEs
24.5%
3.7%
48.3%
6.2%
6.8%
6.3%
100 %
0%
USES
59.9%
37.6%
37.6% -
Net income (loss)
1.2% -
Other operating activities
0.6% -
Deferred income taxes
0.4% -
Prepaid expenses and other assets
0.4% -
(Income) loss from equity method investments
|
|
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|
Net income (loss) | $64,792 | $81,466 | ($191,797) | $208,847 | $216,164 | |||
Depreciation and amortization
|
75,003 | 71,900 | 124,940 | 157,829 | 143,048 | |||
Amortization of deferred financing costs
|
934 | 735 | 34,476 | 389 | 384 | |||
Stock-based compensation
|
18,845 | 21,828 | 32,395 | 50,443 | 73,300 | |||
ESOP stock repurchase agreement and stock-based compensation
ESOP stock repurchase agreement and stock-based compensation
|
18,845 | 21,828 | - | - | - | |||
ESOP special dividend compensation
|
- | - | 246,752 | - | - | |||
Deferred income taxes
|
(11,239) | 12,813 | (2,924) | (9,858) | (18,344) | |||
(Income) loss from equity method investments
|
739 | 95 | (1,909) | (3,520) | - | |||
Inventory step up related to Infiltrator Water Technologies acquisition
Inventory step up related to Infiltrator Water Technologies acquisition
|
- | - | 7,880 | - | - | |||
(Gain) loss on sale of assets and related costs
|
12,655 | 3,647 | 5,338 | 4,126 | 3,920 | |||
Gain on bargain purchase of PTI acquisition
|
- | - | - | - | - | |||
Loss on purchase of non-controlling interest
|
- | - | - | - | - | |||
Change in fair value of derivative
|
(3,244) | 2,346 | 3,128 | (312) | (4,328) | |||
Other operating activities
|
1,010 | (5,219) | (6,005) | 6,170 | 25,592 | |||
Receivables
|
(4,327) | (17,953) | 5,170 | (33,193) | 290,432 | |||
Inventory
|
(4,841) | (2,034) | 19,086 | 22,578 | (55,416) | |||
Prepaid expenses and other assets
|
1,648 | (1,004) | (1,929) | (2,800) | 5,512 | |||
Accounts payable accrued expenses and other liabilities
Accounts payable accrued expenses and other liabilities
|
(14,855) | (16,942) | 31,588 | 55,649 | (31,392) | |||
Cash (used in) provided by working capital | - | - | - | - | - | |||
Net cash provided by (used in) operating activities | $137,120 | $151,678 | $306,189 | $458,647 | $650,432 |
Selected Year:
31-Mar
2020
2020
INVESTING ACTIVITIES
Cash spent on acquiring plant, equipment and other businesses, cash recei0 from sale of plant, equipment and subsidiaries as well cash parked temporarily in different securities - government bonds typically
0.6% -
Other investing activities
SOURCEs
99.4%
100 %
0%
USES
5.8%
94.2%
94.2% -
Acquisition of Infiltrator Water Technologies net of cash acquired
5.8% -
Capital expenditures
|
|
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|
Capital expenditures
|
(41,709) | (43,412) | (67,677) | (79,059) | (114,864) | |||
(Purchase) sale of property plant and equipment
|
- | - | - | - | - | |||
Issuance of note receivable to related party
|
- | - | - | - | - | |||
Acquisitions
|
(1,990) | - | - | - | - | |||
Acquisition of Infiltrator Water Technologies net of cash acquired
Acquisition of Infiltrator Water Technologies net of cash acquired
|
- | - | (1,089,322) | - | - | |||
Sale of assets or businesses
|
- | - | - | - | - | |||
Acquisition or sale of an equity method investment
|
- | - | - | - | - | |||
Sale of corporate-owned life insurance
|
13,644 | - | - | - | - | |||
Other investing activities
|
(390) | 868 | 6,529 | 7,292 | 244 | |||
Net cash provided by (used in) investing activities | ($30,445) | ($42,544) | ($1,150,470) | ($71,767) | ($114,620) |
Selected Year:
31-Mar
2020
2020
FINANCING ACTIVITIES
Items in this group are concerned with borrowing funds, repaying debt, issuing equity, buying back shares, etc.
37.2% -
Borrowing under Term Loan
18.6% -
Issuance of Senior Notes
15.6% -
Issuance of common stock
14.8% -
Borrowing under Revolving Credit Facility
13.5% -
Proceeds from PNC Credit Agreement
0.4% -
Proceeds from issuance of stock upon exercise of stock options
SOURCEs
37.2%
18.6%
14.8%
13.5%
15.6%
100 %
0%
USES
53.7%
4.9%
20.6%
9.4%
5.3%
20.6% -
Payments on PNC Credit Agreement
9.4% -
Repayment of Revolving Credit Facility
5.3% -
Payments on Prudential Senior Notes
4.9% -
Dividends paid
2.7% -
Repayment of Term Loan
1.8% -
Debt issuance costs
1.4% -
Repayment of finance leases
0.0% -
Other financing activities
|
|
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|
Initial Public Offering (IPO) net
|
- | - | - | - | - | |||
Issuance of common stock
|
- | - | 293,648 | - | - | |||
Proceeds from issuance of stock upon exercise of stock options
Proceeds from issuance of stock upon exercise of stock options
|
9,087 | 5,908 | 8,163 | 8,163 | - | |||
Deferred initial public offering costs
|
- | - | - | - | - | |||
Borrowing under Revolving Credit Facility
|
487,850 | 405,700 | 277,900 | 100,000 | - | |||
Repayment of Revolving Credit Facility
|
(512,150) | (442,800) | (177,900) | (100,000) | - | |||
Payments on PNC Credit Agreement
|
(512,150) | (442,800) | (388,300) | - | - | |||
Proceeds from PNC Credit Agreement
|
487,850 | 405,700 | 253,900 | - | - | |||
Borrowing under Term Loan
|
- | - | 700,000 | - | - | |||
Repayment of Term Loan
|
(72,500) | - | (51,750) | (205,250) | (407,000) | |||
Issuance of Senior Notes
|
75,000 | - | 350,000 | - | - | |||
Payments on Prudential Senior Notes
|
(25,000) | (25,000) | (100,000) | - | - | |||
Payments on Senior Notes
|
(25,000) | (25,000) | - | - | - | |||
Equipment financing loans
|
- | (909) | - | - | - | |||
Borrowing under notes mortgages and other debt
|
- | - | - | - | - | |||
Repayment of notes mortgages and other debt
|
(1,905) | (940) | - | - | - | |||
Payments on loans against CSV life insurance policies
|
- | - | - | - | - | |||
Payments on loans against corporate-owned life insurance
Payments on loans against corporate-owned life insurance
|
- | - | - | - | - | |||
Repayment of finance leases
|
(24,214) | (24,284) | (27,119) | (24,554) | (20,728) | |||
Repayments of capital leases
|
(24,214) | (24,284) | - | - | - | |||
Debt issuance costs
|
(2,268) | - | (34,606) | - | - | |||
Acquisition of non-controlling interest in BaySaver
|
- | (8,821) | - | - | - | |||
Dividends paid
|
(18,478) | (26,148) | (92,127) | (32,788) | (36,420) | |||
Repurchases of common stock
|
(7,947) | - | - | - | - | |||
Other financing activities
|
(2,428) | (361) | (237) | (1,490) | - | |||
Net cash provided by (used in) financing activities | ($94,953) | ($117,655) | $1,011,572 | ($259,960) | ($461,292) |
Selected Year:
31-Mar
2020
2020
NET CHANGE IN CASH
Grand Total for sum of cash flows coming from operations, investing and financing
$165,342,000
|
|
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|
Cash and equivalents - Beginning of period | $6,450 | $17,587 | $8,891 | $272,545 | - | |||
Effect of changes in foreign exchange rates on cash | (585) | (175) | (1,949) | (1,236) | 5,932 | |||
(Decrease) increase in cash and cash equivalents | 11,137 | (8,696) | 165,342 | 125,684 | 80,452 | |||
Cash and equivalents - End of period | $17,587 | $8,891 | $174,233 | $474,150 | $80,452 |